Johnson & Johnson

NYSE:JNJHealthcareDJ:DJANASDAQ:NQUSLG

$253.79−0.69%At closeAt close · Tue 20 Oct · ≈ AED 932.04 · Market cap $611.61B · Next earnings Tue 26 Jan · Extended $253.63 −0.06%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	65.6%	70.3%	69.3%	68.8%	69.1%	72.8%	—	—
Operating margin	23.9%	26.6%	26.3%	27.5%	24.9%	27.2%	27.2%	+0.0 pts
Net margin	17.8%	26.5%	22.4%	41.3%	15.8%	28.5%	28.5%	+0.0 pts
EBITDA margin	29.0%	34.0%	33.3%	27.4%	27.9%	43.6%	—	—
Return on equity	23.3%	28.2%	23.4%	51.1%	19.7%	32.9%	32.9%	+0.0 pts
Return on assets	8.4%	11.5%	9.6%	21.0%	7.8%	13.5%	13.5%	+0.0 pts
Return on capital employed	14.9%	15.3%	16.0%	19.3%	17.1%	17.6%	—	—
Debt / equity	0.6×	0.5×	0.5×	0.4×	0.5×	0.6×	0.6×	+0.0%
Debt / assets	20.2%	18.5%	21.2%	17.5%	20.3%	24.1%	—	—
Interest coverage	98.2×	114.4×	76.1×	30.3×	29.3×	26.4×	—	—
Current ratio	1.2×	1.3×	1.0×	1.2×	1.1×	1.0×	1.0×	+0.0%
Quick ratio	1.0×	1.1×	0.8×	0.9×	0.9×	0.8×	—	—
Cash ratio	0.3×	0.3×	0.2×	0.5×	0.5×	0.4×	0.4×	+0.0%
Asset turnover	0.5×	0.4×	0.4×	0.5×	0.5×	0.5×	—	—
Inventory turnover	3.0×	2.3×	2.4×	2.4×	2.2×	1.8×	—	—
Receivables turnover	6.1×	4.1×	4.7×	5.7×	4.7×	5.5×	—	—
Dividend payout	71.2%	52.8%	65.1%	33.5%	84.1%	46.2%	—	—